Pharming Group (PHAR)
10.00
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
Pharming Group Revenue (TTM): 245.32M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 245.32M |
| September 30, 2023 | 218.72M |
| June 30, 2023 | 206.30M |
| March 31, 2023 | 201.55M |
| December 31, 2022 | 205.62M |
| September 30, 2022 | 203.77M |
| June 30, 2022 | 202.40M |
| March 31, 2022 | 201.92M |
| December 31, 2021 | 198.87M |
| September 30, 2021 | 200.11M |
| June 30, 2021 | 205.77M |
| March 31, 2021 | 201.37M |
| December 31, 2020 | 212.17M |
| September 30, 2020 | 212.58M |
| June 30, 2020 | 200.42M |
| March 31, 2020 | 204.20M |
| December 31, 2019 | 189.39M |
| September 30, 2019 | 175.34M |
| June 30, 2019 | 174.45M |
| March 31, 2019 | 157.78M |
| December 31, 2018 | 154.58M |
| September 30, 2018 | 155.11M |
| June 30, 2018 | 141.20M |
| March 31, 2018 | 127.35M |
| December 31, 2017 | 107.52M |
| Date | Value |
|---|---|
| September 30, 2017 | 73.55M |
| June 30, 2017 | 45.88M |
| March 31, 2017 | 30.71M |
| December 31, 2016 | 16.69M |
| September 30, 2016 | 12.04M |
| June 30, 2016 | 11.83M |
| March 31, 2016 | 12.42M |
| December 31, 2015 | 11.84M |
| September 30, 2015 | 30.43M |
| June 30, 2015 | 28.17M |
| March 31, 2015 | 25.74M |
| December 31, 2014 | 25.76M |
| September 30, 2014 | 6.275M |
| June 30, 2014 | 6.533M |
| March 31, 2014 | 10.78M |
| December 31, 2013 | 9.451M |
| September 30, 2013 | 19.20M |
| June 30, 2013 | 18.18M |
| March 31, 2013 | 13.48M |
| December 31, 2012 | 14.04M |
| September 30, 2012 | 3.859M |
| June 30, 2012 | 4.225M |
| March 31, 2012 | 4.160M |
| December 31, 2011 | 3.887M |
| September 30, 2011 | 3.615M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
174.45M
Minimum
Jun 2019
245.32M
Maximum
Dec 2023
203.17M
Average
202.40M
Median
Jun 2022
Revenue (TTM) Benchmarks
| uniQure NV | 15.84M |
| ProQR Therapeutics NV | 7.046M |
| Merus NV | 43.95M |
| argenx SE | 1.226B |
| Pharvaris NV | -- |